Bernd Kaina

26.2k citations

328 papers · 21.1k indexed · 5 hit papers · h-index 78

Impact in

Cancer Research top 0.1%
- Carcinogens and Genotoxicity Assessment
Genetics top 0.1%
- Glioma Diagnosis and Treatment

Papers in

Cancer Research 106
- Carcinogens and Genotoxicity Assessment 69
Genetics 53
- Glioma Diagnosis and Treatment 52

Co-authors: Wynand P. Roos Gerhard Fritz Markus Christmann Maja Tomičić Thomas Efferth Adam D. Thomas Teodora Nikolova Steffen C. Naumann
Journals: Carcinogenesis (17 papers)International Journal of Cancer (14 papers)DNA repair (14 papers)Cancer Research (9 papers)Archives of Toxicology (9 papers)
Partner nations: Germany United States Switzerland

In The Last Decade

Bernd Kaina

326 papers receiving 20.8k citations

Hit Papers

5 papers align trajectories log scale

DNA damage and the balance between survival and death in cancer biology 2015 · 886 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 Nature reviews. Cancer
2012 Cancer Letters
2007 DNA repair
2006 Trends in Molecular Medicine
1999 International Journal of Cancer

Peers

Countries citing papers authored by Bernd Kaina

Since Specialization

Citations

This map shows the geographic impact of Bernd Kaina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernd Kaina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernd Kaina more than expected).

Fields of papers citing papers by Bernd Kaina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernd Kaina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernd Kaina. The network helps show where Bernd Kaina may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Bernd Kaina, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bernd Kaina Line = papers co-authored together Bernd Kaina links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	IDH1 Mutation Impacts DNA Repair Through ALKBH2 Rendering Glioblastoma Cells Sensitive to Artesunate Biomedicines ·Olivier J. Switzeny, Stefan Pusch, Markus Christmann, Bernd Kaina	2025	0
2	Therapy-induced senescence of glioblastoma cells is determined by the p21CIP1-CDK1/2 axis and does not require activation of DREAM Cell Death and Disease ·俊恵大原, Jenny Rinke, 拓馬小川, 金乐琴, 孝寛東, Jesse R. Peel, 闫珂柱, M. N. Hrunchenko, Bernd Kaina, Maja Tomičić, Markus Christmann	2025	3
3	Senescence Is the Main Trait Induced by Temozolomide in Glioblastoma Cells Cancers ·Javier Leonardo Galindo, 俊恵大原, Petra Leukel, Katrin Frauenknecht, Clemens Sommer, F. Vilău, Monika E. Hegi, Markus Christmann, Bernd Kaina	2022	33
4	Abrogation of Cellular Senescence Induced by Temozolomide in Glioblastoma Cells: Search for Senolytics Cells ·Javier Leonardo Galindo, Markus Christmann, Bernd Kaina	2022	26
5	Molecular Dosimetry of Temozolomide: Quantification of Critical Lesions, Correlation to Cell Death Responses, and Threshold Doses Molecular Cancer Therapeutics ·Camilo Andres Carrillo Montoya, Junot Maia, Thảo Nguyễn Song Thanh, Javier Leonardo Galindo, Shana J. Sturla, Bernd Kaina	2021	20
6	Comment of a critical review about the origins of SARS-CoV-2 Zenodo (CERN European Organization for Nuclear Research) ·François Graner, Virginie Courtier‐Orgogozo, Étienne Decroly, Colin D. Butler, Richard H. Ebright, E. Metzger, Bernd Kaina, Monali C. Rahalkar, José Halloy, Rahul A. Bahulikar, Günter Theißen, Milton Leitenberg, Sergé Morand, Hideki Kakeya, Jean‐Michel Claverie, Jacques van Helden	2021	1
7	Targeting c-IAP1, c-IAP2, and Bcl-2 Eliminates Senescent Glioblastoma Cells Following Temozolomide Treatment Cancers ·俊恵大原, 孝寛東, 拓馬小川, M. N. Hrunchenko, Javier Leonardo Galindo, Bernd Kaina, Maja Tomičić, Markus Christmann	2021	25
8	Genotoxic and cytotoxic potential of methacrylate-based orthodontic adhesives Clinical Oral Investigations ·金容熙, Inés Willershausen, Christian Walter, Sarah Al‐Maawi, Bernd Kaina, Lina Gölz	2020	8
9	Benzo[a]pyrene represses DNA repair through altered E2F1/E2F4 function marking an early event in DNA damage-induced cellular senescence Nucleic Acids Research ·新保, Laura Mayer, حسین واعظ, Bernd Kaina, Thomas G. Hofmann, Maja Tomičić, Markus Christmann	2020	30
10	The SIAH1–HIPK2–p53ser46 Damage Response Pathway is Involved in Temozolomide-Induced Glioblastoma Cell Death Molecular Cancer Research ·Thảo Nguyễn Song Thanh, Wynand P. Roos, Qianchao Wu, Thomas G. Hofmann, Bernd Kaina	2019	44
11	Temozolomide Induces Senescence and Repression of DNA Repair Pathways in Glioblastoma Cells via Activation of ATR–CHK1, p21, and NF-κB Cancer Research ·Dorthe Aasland, Nihat DEMİRKOL, Laura Hauck, R. Brenner, OlatunbosunAyokunle Oke, Nordiana Abdul Majid, Simon Schneider, Aleksandar Saša Dundjerovic ́, Wynand P. Roos, Maja Tomičić, Bernd Kaina, Markus Christmann	2018	147
12	Repair gene O⁶‐methylguanine‐DNA methyltransferase is controlled by SP1 and up‐regulated by glucocorticoids, but not by temozolomide and radiation Journal of Neurochemistry ·Dorthe Aasland, Lucia Jazmin Cedeño Rodríguez, Maja Tomičić, Olivier J. Switzeny, Bernd Kaina, Markus Christmann	2017	40
13	Targeting Homologous Recombination by Pharmacological Inhibitors Enhances the Killing Response of Glioblastoma Cells Treated with Alkylating Drugs Molecular Cancer Therapeutics ·R. Brenner, Andrea Piée‐Staffa, Anita Chadha-Patel, Erin Shoe, Kerstin Borgmann, Bernd Kaina, Teodora Nikolova	2016	41
14	Enhanced Histone Deacetylase Activity in Malignant Melanoma Provokes RAD51 and FANCD2-Triggered Drug Resistance Cancer Research ·Niels Buijssen, Christina Barckhausen, Juan Scheun, Karl-Heinz Tomaszowski, Carmen Loquai, Jörg Fahrer, Oliver H. Krämer, Bernd Kaina, Wynand P. Roos	2016	77
15	Translesion Polymerase η Is Upregulated by Cancer Therapeutics and Confers Anticancer Drug Resistance Cancer Research ·Maja Tomičić, Dorthe Aasland, Steffen C. Naumann, Dhay Alaa, Christina Barckhausen, Bernd Kaina, Markus Christmann	2014	52
16	Contribution of ATM and ATR to the Resistance of Glioblastoma and Malignant Melanoma Cells to the Methylating Anticancer Drug Temozolomide Molecular Cancer Therapeutics ·Marcus Eich, Wynand P. Roos, Teodora Nikolova, Bernd Kaina	2013	88
17	Extent and Patterns of MGMT Promoter Methylation in Glioblastoma- and Respective Glioblastoma-Derived Spheres Clinical Cancer Research ·Davide Sciuscio, Annie‐Claire Diserens, 酒井心子, Danielle Martinet, Greg Jones, Robert-Charles Janzer, Claudio Pollo, Marie‐France Hamou, Bernd Kaina, Roger Stupp, Marc Levivier, Monika E. Hegi	2010	68
18	Cisplatin-Induced Apoptosis Involves Membrane Fluidification via Inhibition of NHE1 in Human Colon Cancer Cells Cancer Research ·Amélie Rébillard, Xavier Tekpli, Olivier Meurette, Odile Sergent, Jaap Rooimans, Laurent Vernhet, Morgane Gorria, Martine Chevanne, Markus Christmann, Bernd Kaina, Laurent Counillon, Erich Gulbins, Dominique Lagadic‐Gossmann, Marie‐Thérèse Dimanche‐Boitrel	2007	131
19	BER, MGMT, and MMR in defense against alkylation-induced genotoxicity and apoptosis Progress in nucleic acid research and molecular biology ·Bernd Kaina, ジュンボクカジワラ, Sabine Grösch, Jonas Enzmann, Ashish Jasuja, Maja Tomičić, Torsten Dunkern, Markus Christmann	2001	81
20	Transfer of Human Genes Conferring Resistance to Methylating Mutagens, But N ot to UV Irradiation and Cross-Linking Agents, into Chinese Hamster Ovary Cells Molecular and Cellular Biology ·Bernd Kaina, A.A. van Zeeland, Claude Backendorf, Heinz Walter Thielmann, P. van de Putte	1987	1

About Bernd Kaina

Bernd Kaina is a scholar working on Cancer Research, Genetics, Molecular Biology, Oncology and Pathology and Forensic Medicine, having authored 328 papers that have together received 21.1k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (168 papers), Carcinogens and Genotoxicity Assessment (69 papers), Epigenetics and DNA Methylation (58 papers), Glioma Diagnosis and Treatment (52 papers), Cancer-related Molecular Pathways (46 papers), Cell death mechanisms and regulation (36 papers), Cancer therapeutics and mechanisms (30 papers) and DNA and Nucleic Acid Chemistry (17 papers). The work is most often cited by research in Cancer Research (5.1k citations), Genetics (2.7k citations), Molecular Biology (14.5k citations), Oncology (5.6k citations) and Toxicology (309 citations). Bernd Kaina has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Wynand P. Roos, Gerhard Fritz, Markus Christmann, Maja Tomičić, Thomas Efferth, Adam D. Thomas, Teodora Nikolova, Steffen C. Naumann, Ingo Just and Sankar Mitra. Their work appears in journals such as Carcinogenesis, International Journal of Cancer, DNA repair, Cancer Research and Archives of Toxicology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact